Jonathan Baden - Concepedia

Author

Jonathan Baden

Bristol-Myers Squibb (United States)ORCID

Also Known As

J Baden, J. Baden, J.F. Baden, Jonathan Baden, Jonathan F Baden, Jonathan F. Baden

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Foundation Medicine (United States)Thermo Fisher Scientific (United States)AstraZeneca (United States)Friends of Cancer Research

About

Jonathan Baden is an author at Bristol-Myers Squibb (United States) specializing in oncology, medicine, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	149
2	Health Sciences	2	2	131
3	Immunology	2	2	44
4	Pathology	2	2	131
5	Cancer Therapeutics	1	1	26

Jonathan Baden

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project Diana M. Merino, Lisa M. McShane, David Fabrizio, Journal for ImmunoTherapy of Cancer	2020	491
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451 Taofeek K. Owonikoko, Keunchil Park, Ramaswamy Govindan, Journal of Clinical Oncology	2021	254
Homologous Recombination Deficiency: Concepts, Definitions, and Assays Mark Stewart, Diana Merino Vega, Rebecca C. Arend, The Oncologist	2022	207
Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project Diana Merino Vega, Laura M. Yee, Lisa M. McShane, Annals of Oncology	2021	174
A Quantitative Reverse Transcriptase-Polymerase Chain Reaction Assay to Identify Metastatic Carcinoma Tissue of Origin Dimitri Talantov, Jonathan Baden, Tim Jatkoe, Journal of Molecular Diagnostics OncologyMalignant DiseaseTumor HeterogeneityMedicinePathology	2006	105
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors Diana Merino Vega, Katherine K. Nishimura, Névine Zariffa, JCO Precision Oncology	2022	74
Development of a Multiplexed Urine Assay for Prostate Cancer Diagnosis Tatiana Vener, Carlo Derecho, Jonathan Baden, Clinical Chemistry	2008	59
Multicenter Evaluation of an Investigational Prostate Cancer Methylation Assay Jonathan Baden, George Green, Jennifer M Painter, The Journal of Urology	2009	53
5‐azacytidine alters TGF‐β and BMP signaling and induces maturation in articular chondrocytes Michael J. Zuscik, Jonathan Baden, Qiuqian Wu, Journal of Cellular Biochemistry	2004	48
Predicting Prostate Biopsy Result in Men With Prostate Specific Antigen 2.0 to 10.0 ng/ml Using an Investigational Prostate Cancer Methylation Assay Jonathan Baden, Scott V. Adams, Tara Astacio, The Journal of Urology	2011	45

Page 1